Ads
related to: insm stock price
Search results
Wells Fargo Maintains Overweight on Insmed, Raises Price Target to $77 - Insmed (NASDAQ:INSM)
Benzinga· 6 days agoWells Fargo analyst Tiago Fauth maintains Insmed (NASDAQ:INSM) with a Overweight and raises the price target from $55 to $77.
Unpacking the Latest Options Trading Trends in Insmed - Insmed (NASDAQ:INSM)
Benzinga· 4 days agoWe aim to explore its current performance. Current Position of Insmed With a volume of 1,294,319, the price of INSM is down -2.81% at $55.38. RSI indicators ...
Why Is P3 Health Partners (PIII) Stock Down 4% Today?
InvestorPlace· 7 days agoP3 Health Partners (NASDAQ:PIII) stock is falling on Tuesday after the company sold shares and...
Morgan Stanley raises Insmed target to $60 on positive ASPEN data By Investing.com
Investing.com· 7 days agoOn Tuesday, Morgan Stanley (NYSE:MS) updated its outlook for Insmed (NASDAQ:INSM) Incorporated...
Insmed shares rise on positive phase 3 trial results By Investing.com
Investing.com· 7 days agoOn Tuesday, Insmed (NASDAQ:INSM) Incorporated (NASDAQ:INSM) received a reiterated Buy rating and a...
Morgan Stanley leaves Insmed shares target unchanged amid post-study win By Investing.com
Investing.com· 7 days agoOn Tuesday, Morgan Stanley (NYSE:MS) reiterated its Overweight rating on Insmed shares (NASDAQ:INSM...
Why Is Inflammatory Diseased-Focused Insmed Stock Soaring On Tuesday?
Benzinga via Yahoo Finance· 7 days agoInsmed Incorporated (NASDAQ:INSM) shares are trading higher after the company released topline...
Why Is Inflammatory Diseased-Focused Insmed Stock Soaring On Tuesday?
Benzinga· 7 days agoInsmed Incorporated INSM shares are trading higher after the company released topline results from the ASPEN Phase 3 study of brensocatib in patients with non-cystic fibrosis ...
Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In...
Benzinga· 7 days agoShares of Applied DNA Sciences, Inc. APDN fell sharply during Tuesday's session after the company...
Insmed Announces Proposed $500 Million Public Offering of Common Stock
WLNS Lansing· 6 days agoInsmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that ...